Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence

Hypertension is one of the most common morbidities in COVID-19. Previous studies demonstrated that hypertension increases composite poor outcomes in patients with COVID-19. Beta-blockers is widely used as one of the most common antihypertensive agents. Beta-blockers may hold potential benefits in CO...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mochamad Yusuf Alsagaff, Eka Prasetya Budi Mulia
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/052af62d733549f38d2a5ef5588abc55
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!